A distribution-led healthcare group with steady sales and working-capital-sensitive cash generation
Across the reported years, Shanghai Pharmaceuticals has expanded revenue steadily, but its wholesale-heavy mix leaves operating margins narrow. It generates positive free cash flow with limited fixed-asset spending, while working-capital requirements make quarterly cash conversion uneven.